Results of a new trial suggest that certain probiotics can improve mental health, metabolic function, and disability among individuals with multiple sclerosis. This study is just one of several that has explored the impact of beneficial bacteria on the symptoms and progression of multiple sclerosis.
Ads by Google
Some people are skeptical about how much impact diet has on multiple sclerosis, yet at the same time there’s quite a bit of interest in the topic, especially since making dietary changes is a drug-free way to help manage the disease. Therefore it’s important to consider recently published research showing how a plant based diet benefits multiple sclerosis.
A plant based diet for MS
Previous research has suggested a link between obesity and an increased risk of multiple sclerosis, but some experts have questioned the validity of those findings because of bias related to study design. Now a new study has clarified the association between obesity and MS risk, using a model shown to significantly minimize bias and establish causality.
Previous studies of obesity and multiple sclerosis
Study results from both human and animal research indicate that a fasting diet could be effective for treating multiple sclerosis. The latest research, from the University of Southern California, showed that the fasting diet (aka, fasting-mimicking diet, FMD) reversed symptoms of multiple sclerosis in some animals and reduced them in others while improving symptoms in patients.
One critical component of the fasting type diet is the production of a substance called corticosterone.
The findings of a systematic review indicate that adolescent obesity could be a risk factor for multiple sclerosis. If future research supports this idea, it “would be of major significance,” according to experts at the University of British Columbia, especially given the rising number of children and adolescents who are overweight or obese.
Scientists around the world have been searching for the causes and risk factors for multiple scleros
The number of people with multiple sclerosis who experience taste problems (aka, taste deficits) is unclear, although some experts believe it ranges from 5 to 20 percent of individuals with MS. A new study from a team at the University of Pennsylvania’s Smell and Taste Center decided to explore this issue further.
Some people with multiple sclerosis decide to avoid yoga because they believe they won’t be able to do the poses or may feel embarrassed if they can’t keep up with others in the class. However, fortunately there is adaptive yoga for multiple sclerosis, which can make this beneficial form of exercise available to just about anyone.
The National Multiple Sclerosis Society explains that yoga can help individuals who have multiple sclerosis “as long as they find the appropriate class, teacher or video.” In recent years, a growin
Researchers are looking for volunteers for a new multiple sclerosis genetics study. The two populations of individuals needed are African Americans with multiple sclerosis, and their family members, as well as individuals of Northern European descent with MS.
Although the study is being conducted by researchers at the University of California in San Francisco (UCSF), participants can live anywhere in the United States and no travel or cost is involved.
Hematopoietic stem cell transplantation, which is commonly used for patients with blood and bone marrow cancers, has been the focus of several studies for people who have multiple sclerosis. Now a new report from an Australian team offers some insight into this treatment approach, including which MS patients seem to be the most likely to benefit from it.
Hematopoietic (meaning “formation of blood or blood cells”) stem cell transplantation for multiple sclerosis is a tech
If upcoming study results are positive, people with multiple sclerosis may have a marijuana gum available for treatment of symptoms by 2017. The gum is made by AXIM Biotechnology, Inc. and is called MedChew Rx.
The marijuana gum has been tested for treatment of pain and spasticity in multiple sclerosis, and the